Teva Pharmaceutical (TEVA -0.4%) says the FDA has accepted for filing its New Drug Application...

|About: Teva Pharmaceutical Industr... (TEVA)|By:, SA News Editor

Teva Pharmaceutical (TEVA -0.4%) says the FDA has accepted for filing its New Drug Application for Quartette, the first ascending-dose, extended regimen oral contraceptive. The submission was based on its successful clinical development program including results from Phase I, Phase II, and Phase III trials designed to evaluate the drugs safety and efficacy.